US 7776607
Mammalian selenoprotein differentially expressed in tumor cells
granted A61KA61K38/00
Quick answer
US patent 7776607 (Mammalian selenoprotein differentially expressed in tumor cells) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K38/00